High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats
- PMID: 1516060
High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats
Abstract
The carcinogenicities of a choline deficient L-amino acid defined (CDAA) diet and a semipurified choline deficient diet were comparatively examined. A total of 60 male Fischer 344 rats, 6 weeks old, were divided into 5 experimental groups each consisting of 12 rats. Group 1 received the CDAA diet chronically to the end of the 52-week experiment while Group 2 was given the same diet for the first 24 weeks and then a basal diet for the following 28 weeks. Groups 3, 4, and 5 received a choline supplemented L-amino acid defined diet, the semipurified choline deficient diet, and a semipurified choline supplemented diet, respectively, throughout the experimental period. All surviving rats were subjected to complete macroscopic examination at Week 52. Histopathologically diagnosed hepatocellular carcinomas were induced in Group 1 at an incidence of 100%; multiple metastatic nodules were seen in the lungs of one of the animals. Hepatocellular carcinomas were also induced in Group 4 rats at a significantly lower incidence of 20%. No hepatocellular carcinomas were observed in rats in Groups 2, 3, and 4. The results indicate that the CDAA diet exerts more potent carcinogenicity for the livers of rats than does the semipurified choline deficient diet. However, limited exposure for 24 weeks may have not been sufficient for hepatocellular carcinoma induction by the CDAA diet at Week 52 although a high incidence of hyperplastic nodules and slight cirrhosis were evidence of persistent lesions.
Similar articles
-
No enhancement by phenobarbital of the hepatocarcinogenicity of a choline-devoid diet in the rat.Res Commun Chem Pathol Pharmacol. 1990 Aug;69(2):197-207. Res Commun Chem Pathol Pharmacol. 1990. PMID: 2396046
-
Fhit gene alterations in hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet in rats.Mol Carcinog. 2003 Mar;36(3):147-52. doi: 10.1002/mc.10104. Mol Carcinog. 2003. PMID: 12619037
-
Inhibition of the development of hepatocellular carcinomas by phenyl N-tert-butyl nitrone in rats fed with a choline-deficient, L-amino acid-defined diet.Cancer Lett. 2004 Mar 31;206(1):1-13. doi: 10.1016/j.canlet.2003.10.003. Cancer Lett. 2004. PMID: 15019154
-
Endogenous liver carcinogenesis in the rat.Pathol Int. 1999 Dec;49(12):1028-42. doi: 10.1046/j.1440-1827.1999.00990.x. Pathol Int. 1999. PMID: 10632923 Review.
-
Methyl group deficiency in hepatocarcinogenesis.Drug Metab Rev. 1994;26(1-2):185-99. doi: 10.3109/03602539409029790. Drug Metab Rev. 1994. PMID: 8082564 Review. No abstract available.
Cited by
-
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats.Gut. 2006 Jul;55(7):1020-9. doi: 10.1136/gut.2005.079194. Epub 2006 Feb 16. Gut. 2006. PMID: 16484506 Free PMC article.
-
Alterations of the transforming growth factor-beta signaling pathway in hepatocellular carcinomas induced endogenously and exogenously in rats.Jpn J Cancer Res. 2001 Jan;92(1):16-22. doi: 10.1111/j.1349-7006.2001.tb01042.x. Jpn J Cancer Res. 2001. PMID: 11173539 Free PMC article.
-
Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents.Environ Mol Mutagen. 2008 Jan;49(1):9-15. doi: 10.1002/em.20342. Environ Mol Mutagen. 2008. PMID: 17879298 Free PMC article. Review.
-
NLRP3 inflammasome activation is required for fibrosis development in NAFLD.J Mol Med (Berl). 2014 Oct;92(10):1069-82. doi: 10.1007/s00109-014-1170-1. Epub 2014 May 28. J Mol Med (Berl). 2014. PMID: 24861026 Free PMC article.
-
An update on animal models of liver fibrosis.Front Med (Lausanne). 2023 Mar 23;10:1160053. doi: 10.3389/fmed.2023.1160053. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37035335 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical